Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01526473
Title A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors H. Kim Lyerly
Indications

gastric adenocarcinoma

Advanced Solid Tumor

Her2-receptor positive breast cancer

gastroesophageal junction adenocarcinoma

esophagus adenocarcinoma

Therapies

AVX901

Age Groups: adult
Covered Countries USA


No variant requirements are available.